Overexpression of wild‐type Fto into mouse cardiomyocytes, rather than its catalytically inactive mutant, reduces atrial Kcne1 protein levels, causes shortening of APD90, enhances IKs current, and increases AF inducibility. The gene discussed is FTO; the disease is atrial fibrillation.